Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Launches Native Apps Program to Broaden BaseSpace's Reach

Premium

Making good on a promise it made about a year ago (BI 11/2/2012), this week Illumina launched a native application development program for BaseSpace that will offer tools that members of the general bioinformatics community can use to develop and run apps on its cloud infrastructure.

Initially, when Illumina launched BaseSpace on Amazon Web Services in April 2012, it focused on populating the platform with a mix of internally developed apps and apps developed by commercial partners such as Diagnomics, GenoLogics Life Sciences, Genomatix, Golden Helix, Ingenuity Systems, Knome, Omicia, Spiral Genetics, Omixon, Real Time Genomics, Station X, Integromics, Biomax Informatics, Biomatters, and Strand Life Sciences (BI 8/24/2012).

With the so-called Illumina native app engine program — which was launched during a developer meeting at the American Society of Human Genetics conference in Boston this week — Illumina is hoping to encourage participation from members of the broader life science community, including bioinformatics professionals, academics, and graduate students, Alex Dickinson, the company's senior vice president for cloud genomics, told BioInform.

The native apps program offers an "inviting environment" for these folks, he said, that includes software development kits written in the Java, Python, and Ruby programming languages. Interested researchers also have tools to create a user interface through which data can be uploaded and extracted from the cloud, and are provided with an infrastructure for hosting and running the apps.

To users, these apps will look exactly the same as those developed by Illumina's commercial partners, Dickinson said. They'll also be priced using the financial arrangement that Illumina operates with those vendors. Under the model, the developers themselves determine the apps' price points and receive 70 percent of revenues while Illumina takes 30 percent. Alternatively, developers can choose to run the apps at cost, meaning that customers will only have to pay to run their analyses on Amazon and the developers do not make any profits — an option that Illumina expects will likely appeal to academic developers.

Illumina launched BaseSpace about two years ago initially to provide free data-management, archiving, analysis, sharing, and storage tools for MiSeq users with plans to eventually integrate the cloud with its HiSeq sequencers as well (BI 10/14/2011).

Anticipating a bump in demand for analysis and storage space when the HiSeq was integrated with BaseSpace, last year Illumina decided to put a pricing structure in place that would limit the amount of free space for storing and processing genomic data in the cloud. Under the scheme, users would get one terabyte of free cloud space for storing and processing data and would then be able to purchase additional storage in increments of one terabyte or 10 terabytes — one terabyte would cost $250 per month or $2,000 upfront for a full year, while 10 terabytes would be $1,500 per month or an annual upfront fee of $12,000 (BI 7/27/2012).

Overall, the company is "pretty thrilled about how BaseSpace has been adopted" since its launch, Dickinson said. Currently, it has over 10,000 registered users analyzing and sharing data, with about 200 new participants joining the community each week. There are 20 apps available for use in BaseSpace, about half of which Illumina developed internally and the other half come from third-party development partners. Dickinson expects the number of apps to grow by about 50 percent by the end of the year.

"Illumina's interested in making sequencing a more valuable thing," and BaseSpace is its attempt to help researchers move from generating data to extracting knowledge from data, he said. "We want to create this environment and incent people … to put new and interesting applications up there that are going to help users actually extract knowledge out of the data."

Allowing developers to set their own pricing appears to have been a sound decision for the company but time will tell. "So far it's been smooth sailing, but we are in the very early stages of commercialization," Dickinson said.

Most of the companies that have developed apps for BaseSpace have chosen to make them free for users but, he said, it's possible that in the future some firms might decide to offer both free and priced versions of their apps, with the latter providing more features than the former. "I think that’s still shaking out, but it's too early to tell," he said.

Filed under

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.